Neha Verma | Biotechnology | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Neha Verma | Biotechnology | Best Researcher Award

Sharda University | India

Neha Verma is a dedicated biotechnology researcher currently pursuing her Ph.D. at Sharda University, research experience in molecular biology, cell culture, spectroscopy, and bioinformatics. She has significantly contributed to cancer and osteoporosis research, with numerous publications in reputed journals and several patents to her credit. Her expertise encompasses a range of technical proficiencies including FACS, RT-PCR, HPLC, GC-MS, LC-MS, NMR, FT-IR, and advanced microscopy. She has actively participated in multiple national and international conferences and workshops, earning recognition for her work. She has co-authored book chapters with reputed publishers like Elsevier and is the recipient of prestigious awards such as Best Oral Presentation, Best Research Scholar, Silver Medal, and Young Scientist Award. Neha’s research blends experimental biology with computational techniques, reflecting a multidisciplinary approach. With a commitment to innovation and translational research, she aims to make meaningful contributions to biomedical sciences through novel therapeutic strategies.

Profile

Googlescholar

 Education

Neha Verma has built a strong academic foundation in the life sciences and biotechnology domain. She is currently pursuing her Ph.D. in Biotechnology with coursework from the Department of Life Sciences at Sharda University, where her research involves a multidisciplinary approach combining cell culturing, phytochemical analysis, and bioinformatics modeling. Prior to this, she earned her M.Sc. in Biotechnology from Himalayan University, where she developed core competencies in laboratory techniques and research methodologies. She began her academic journey with a B.Sc. in Life Sciences, which laid the groundwork for her interest in molecular biology and biochemistry. Throughout her education, she has consistently demonstrated academic excellence, contributing to scientific publications, attending scientific forums, and actively engaging in workshops and webinars related to spectroscopy, AI tools in science, and genetic disorders. Her academic path reflects a progressive learning trajectory that aligns closely with her current research goals and future aspirations in translational biotechnology

Experience

Neha Verma possesses over five years of extensive hands-on research experience in biotechnology, particularly in molecular biology, animal cell culturing, and the isolation and application of plant-based bioactives. Her professional exposure spans several advanced analytical and spectroscopic platforms such as HPLC, GC-MS, LC-MS, NMR, and FT-IR, used primarily for metabolite profiling and compound identification. She has worked on osteogenic differentiation and anticancer studies using plant extracts, evidenced by her co-authorship on high-impact journal articles and patented innovations. She has cultivated skills in experimental planning, data analysis using GraphPad and Excel, and bioinformatics tools like molecular docking and Swiss target prediction. Neha has participated in several high-end workshops funded by DST-SERB and DBT, as well as training programs on good laboratory practices and 3D cell culture technology. Her experience also includes contributing to international book chapters and conference presentations, showcasing her commitment to knowledge dissemination and interdisciplinary research collaboration.

Awards and Honors

Neha Verma has earned multiple prestigious awards recognizing her research excellence and scientific contributions. She received the Best Oral Presentation Award at a DBT-funded National Conference focused on Disease Diagnosis and Drug Development.  she was honored with the Best Research Scholar Award at the 6th International Conference on Cutting-edge Solutions in Science, Technology, Engineering, and Humanities. Her achievements also include receiving the Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology. Additionally, she was conferred the Young Scientist Award at the 4th Annual Meeting of the International Association of Zoologists. These accolades reflect her sustained efforts in innovative biotechnology research, her impactful presentations at scientific forums, and her leadership in driving translational outcomes. Her work in cancer and osteoporosis research has consistently gained academic and peer recognition.

Research Focus

Neha Verma’s research is centered on biotechnology applications in cancer and osteoporosis, particularly through the use of plant-derived bioactive compounds. She investigates the therapeutic potential of phytochemicals on osteogenic differentiation and anticancer activity, integrating molecular biology techniques like RT-PCR and FACS with spectroscopic tools such as HPLC, GC-MS, LC-MS, and NMR for compound analysis. Her studies also extend to bioinformatics, where she employs molecular docking and target prediction to elucidate mechanistic pathways. Neha’s scientific approach is highly interdisciplinary, blending traditional ethnopharmacology with modern experimental and computational methods. Her work has led to several granted and published patents focusing on anticancer and anti-osteoporotic agents. With contributions to journals, conferences, and book chapters, she aims to bridge the gap between natural products research and clinical translational outcomes in biotechnology.

Publications

 

Title: Occupational health hazards and wide spectrum of genetic damage by the organic solvent fumes at the workplace: A critical appraisal
Year: 2022
Citations: 10

Title: Recent Update on Active Biological Molecules in Generating the Anticancerous Therapeutic Potential of Garcinia mangostana
Year: 2022
Citations: 9

Title: A review on therapeutic mechanism of medicinal plants against osteoporosis: effects of phytoconstituents
Year: 2023
Citations: 6

Title: Sustainable synthesis of magnetic nanoparticles: biological applications of Cedrus deodara extract
Year: 2025
Citations: 1

Conclusion

Neha Verma is an accomplished biotechnology researcher whose interdisciplinary expertise, impactful publications, patents, and awards reflect her commitment to advancing therapeutic innovations in cancer and osteoporosis through integrated experimental and computational approaches.

Fan Zhang | Proteomics | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Fan Zhang | Proteomics | Best Researcher Award

Fan Zhang, born on September 23, 1991, is a postdoctoral researcher specializing in cancer proteogenomics 🔬. He is currently with the Department of Pathology at Duke University 🏛️. His research leverages mass spectrometry and bioinformatics 🖥️ to investigate metabolic pathways in therapy-resistant prostate cancer and other malignancies. He has received the FY23 Prostate Cancer Research Program Early Investigator Research Award 🏆 for his work on glutamine metabolism in advanced prostate cancer. His contributions to proteogenomics have resulted in multiple high-impact publications 📄 in Nature Communications, Cell Research, and Molecular & Cellular Proteomics. Proficient in LC-MS/MS, bioinformatics analysis, and experimental techniques, his research bridges the gap between basic cancer biology and clinical applications 🏥, paving the way for novel therapeutic strategies in oncology.

Profile

Education 🎓

Fan Zhang holds a Ph.D. in Biochemistry and Molecular Biology from Fudan University (2015-2020), where he focused on proteogenomic research. He further pursued postdoctoral training in Clinical Medicine at Fudan University (2020-2022) before joining Duke University as a postdoctoral researcher in the Department of Pathology in 2023. His academic journey began with a B.S. in Applied Biological Science from Anhui Agricultural University (2011-2015). Throughout his education, he gained expertise in genomics, transcriptomics, and proteomics, developing a strong foundation in bioinformatics and experimental methodologies. His interdisciplinary training has equipped him with skills in mass spectrometry-based proteomics, omics data analysis, and cancer metabolism research. His current research at Duke University focuses on metabolic vulnerabilities in prostate cancer, aiming to develop targeted therapies. His diverse academic background enables him to integrate various scientific disciplines, contributing significantly to cancer research and precision medicine.

Experience 👨‍🏫

Fan Zhang has extensive research experience in cancer proteogenomics. Currently a postdoctoral researcher at Duke University (2023-present), he investigates metabolic vulnerabilities in prostate cancer using advanced mass spectrometry and omics analysis. Previously, he was a postdoc in Clinical Medicine at Fudan University (2020-2022), where he contributed to proteogenomic studies on various cancers, including pituitary neuroendocrine tumors and diffuse large B-cell lymphoma. His Ph.D. at Fudan University (2015-2020) focused on proteogenomic characterizations of cancer, leading to high-impact publications. He is proficient in LC-MS/MS, bioinformatics, and experimental methodologies such as Western blotting, immunofluorescence, and cell culture. His research integrates mass spectrometry with genomics and transcriptomics to uncover novel therapeutic targets. With expertise in multi-omics data analysis, he has significantly contributed to the field of cancer biology. His work is supported by prestigious grants, highlighting his role as a leading researcher in proteogenomics and precision oncology.

Research Interests 🔬

Fan Zhang’s research focuses on proteogenomics and cancer metabolism, particularly in therapy-resistant malignancies like prostate cancer, pituitary neuroendocrine tumors, and diffuse large B-cell lymphoma. He specializes in mass spectrometry-based proteomics (DDA, DIA) and integrates multi-omics approaches, including genomics, transcriptomics, and metabolomics, to uncover novel cancer vulnerabilities. His current work at Duke University investigates glutamine metabolism in castration-resistant prostate cancer, aiming to develop targeted therapies. His expertise extends to bioinformatics analysis, large-cohort omics data interpretation, and advanced LC-MS/MS techniques for various biological samples. His research has led to multiple high-impact publications, highlighting his ability to translate complex molecular data into potential clinical applications. By combining experimental and computational approaches, he aims to identify biomarkers and therapeutic targets that can improve cancer treatment. His contributions to proteogenomics play a crucial role in advancing precision oncology and understanding the metabolic reprogramming of aggressive cancers.

 

Awards & Recognitions 🏅

Fan Zhang has received multiple awards and recognitions for his contributions to cancer proteogenomics. He was awarded the Fiscal Year 2023 (FY23) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (2023-2025) for his project on targeting glutamine metabolism in advanced prostate cancer (Award Number HT9425-24-1-0237). His research has been recognized through multiple first-author and co-first-author publications in high-impact journals such as Nature Communications, Molecular & Cellular Proteomics, Cell Research, and The Prostate. His work has also been featured as a cover article in Cell Research (2022). His expertise in mass spectrometry, proteogenomics, and bioinformatics has positioned him as a leading young investigator in the field. In addition to research grants, he has received accolades for his innovative contributions to metabolic studies in oncology. His commitment to advancing cancer research has been instrumental in developing novel therapeutic strategies for therapy-resistant malignancies.

Publications 📚